These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 8816969

  • 1. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
    Jansen A, Rosmalen JG, Homo-Delarche F, Dardenne M, Drexhage HA.
    J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
    [Abstract] [Full Text] [Related]

  • 2. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A, Suarez WL, Power RF.
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [Abstract] [Full Text] [Related]

  • 3. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ, French MB, Chosich N, Harrison LC.
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [Abstract] [Full Text] [Related]

  • 4. Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse.
    Geutskens SB, Homo-Delarche F, Pleau JM, Durant S, Drexhage HA, Savino W.
    Cell Tissue Res; 2004 Dec; 318(3):579-89. PubMed ID: 15480796
    [Abstract] [Full Text] [Related]

  • 5. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P, Ji RC, Shimoda H, Miura M, Kato S.
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [Abstract] [Full Text] [Related]

  • 6. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V, Toseland CD, Turner NC.
    Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
    [Abstract] [Full Text] [Related]

  • 7. The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans.
    Valorani MG, Hawa MI, Buckley LR, Afeltra A, Cacciapaglia F, Pozzilli P.
    Diabetes Metab Res Rev; 2004 Dec; 20(5):394-8. PubMed ID: 15343585
    [Abstract] [Full Text] [Related]

  • 8. Changes in expression of P2X7 receptors in NOD mouse pancreas during the development of diabetes.
    Coutinho-Silva R, Robson T, Beales PE, Burnstock G.
    Autoimmunity; 2007 Mar; 40(2):108-16. PubMed ID: 17364502
    [Abstract] [Full Text] [Related]

  • 9. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F, Yu M, Zhu Q.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [Abstract] [Full Text] [Related]

  • 10. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I, Fabien N, Thivolet C.
    Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
    [Abstract] [Full Text] [Related]

  • 11. Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration.
    Reddy S, Bai Y, Robinson E, Ross J.
    Ann N Y Acad Sci; 2006 Oct; 1079():103-8. PubMed ID: 17130538
    [Abstract] [Full Text] [Related]

  • 12. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ, Zhou ZG, Su H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
    [Abstract] [Full Text] [Related]

  • 13. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S, Young M, Poole CA, Ross JM.
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [Abstract] [Full Text] [Related]

  • 14. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M, Holz A.
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [Abstract] [Full Text] [Related]

  • 15. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
    Wang H, Li Y, Sun Q, Yang G.
    Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
    [Abstract] [Full Text] [Related]

  • 16. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity.
    Martignat L, Feve B, Charbonnel B, Sai P.
    Diabete Metab; 1993 May; 19(6):566-74. PubMed ID: 8026608
    [Abstract] [Full Text] [Related]

  • 17. A low protein diet in early life delays the onset of diabetes in the non-obese diabetic mouse.
    Chamson-Reig A, Arany EJ, Summers K, Hill DJ.
    J Endocrinol; 2009 May; 201(2):231-9. PubMed ID: 19228796
    [Abstract] [Full Text] [Related]

  • 18. Effect of Tenidap, a novel anti-inflammatory compound on islet lymphocytic infiltration and diabetes incidence in the non obese diabetic (NOD) mouse.
    Beales PE, Williams A, Krug J, Signore A, Chianelli M, Andreani D, Pozzilli P.
    Diabete Metab; 1992 May; 18(1):48-53. PubMed ID: 1563537
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, Taiji M.
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse.
    Dahlén E, Dawe K, Ohlsson L, Hedlund G.
    J Immunol; 1998 Apr 01; 160(7):3585-93. PubMed ID: 9531322
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.